Agora Labs Raises €4.3M to Scale Clinical Data AI

The big picture: P101 has led a €4.3 million investment round in Agora Labs, a deep-tech company developing advanced infrastructure to make clinical data from hospitals usable for medical and scientific research while fully respecting patient privacy.

Why it matters:

• Untapped Data: Hospitals possess a vast wealth of clinical data, invaluable for research and developing new diagnostic and therapeutic tools, yet much of it remains inaccessible due to being scattered across disparate IT systems and often unstructured.
• Accelerated Research: Agora Labs enables multi-center studies on large international populations from different geographical areas, allowing life sciences organizations to accelerate the research and development of new diagnostic and therapeutic solutions.
• Growing Market: The real-world evidence (RWE) market, which Agora Labs operates in, is projected to grow from $5.4 billion in 2025 to $10.8 billion in 2030, driven by the increasing demand for high-quality clinical data to train AI models in healthcare.

How it works:

• Data Stays Local: Agora Labs’ model ensures clinical data never leaves the hospital. A dedicated on-premises computing node, powered by Nvidia GPUs, is installed in each facility to structure and standardize data.
• Secure Anonymization: Specialized large language models (LLMs) are used to process and standardize data, which is then anonymized through irreversible mathematical processes designed to protect patient data even against quantum computing capabilities.
• Federated AI: Federated artificial intelligence algorithms process and standardize data from various hospital nodes. This allows AI models to be trained and validated locally, sharing only computations and inferences for multicenter studies, while hospitals retain full control over their data assets.

The catch: The market for secure clinical data sharing is competitive, with numerous startups and established players vying for hospital partnerships. While Agora Labs’ federated learning approach and quantum-resistant anonymization are strong differentiators, rapidly scaling its international network of healthcare facilities will be crucial to maintain its competitive edge and capture market share in a fragmented landscape.

Key Facts

• Company: Agora Labs
• Amount: €4.3M
• Investors: P101 (lead), Infinite Five
• Founders: Davide Zaccagnini, Fabio Giulietto
• Sector: Clinical Data AI
• Headquarters: Rome, Italy